← Leaderboards
Sichen Shao
Harvard Medical School
$4,542,365
Attributed
$4,542,365
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5M · FY2019–25$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,542,365 · 3
By mechanism
DP2$2,542,500 · 1
R01$1,999,865 · 2
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Tom A Rapoport$14,039,867
- Akhila Rajan$7,584,212
- Joseph Charles Sedlak$185,332
- Marcia Haigis$12,366,449
- Elizabeth Aguilar Perry$190,305
Others in their field
Other Emerging Leaders on “Protein Biosynthesis”
- Ian R Lanza · Mayo Clinic Rochester$9,750,945
- Robert Nicol · Broad Institute, Inc.$7,498,771
- Zhao Wang · Ut Southwestern Medical Center$7,363,143
- Robert A.j. Signer · University Of California, San Diego$5,545,140
- Christine Iok In Chio · Columbia University Health Sciences$4,981,139
- James M Dewar · Vanderbilt University$4,949,419
Research focus
Protein BiosynthesisInsightProteinsQuality ControlRibosomesMolecularCellsProteomeMediatingProteostasisCell PhysiologyHydrophobicityImpairmentDissectionBindingEffective TherapyDislocationsDefectEndoplasmic ReticulumHuntington DiseaseCellular MembraneAtp PhosphohydrolaseAmyotrophic Lateral SclerosisFace
Grant awards (6)
Mechanisms of proteome curation during red blood cell differentiation$616,914
R01 · FY2025 · HL · contact PI
Quality control of mislocalized membrane proteins$340,526
R01 · FY2025 · AG · contact PI
Quality control of mislocalized membrane proteins$347,475
R01 · FY2024 · AG · contact PI
Quality control of mislocalized membrane proteins$347,475
R01 · FY2023 · AG · contact PI
Quality control of mislocalized membrane proteins$347,475
R01 · FY2022 · AG · contact PI
Decoding ribosome-triggered quality control mechanisms$2,542,500
DP2 · FY2019 · GM · contact PI